• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

bioresorbable stent

colorful brain art model
MedTech

Fluid Biomed raises $27M for its bioabsorbable aneurysm stent

Developed by neurosurgeons at the University of Calgary, the polymer-metal ReSolv stent slows the flow of blood to form a clot within the aneurysm.
Conor Hale Dec 16, 2024 11:00am
Abbott Espirit BTK

Abbott posts positive, longer-term data for its Esprit BTK stent

Nov 5, 2024 11:00am
Red blood cells

R3 Vascular raises $87M for bioresorbable, below-the-knee stent

May 17, 2024 12:31pm
Abbott Espirit BTK

FDA approves Abbott dissolving stent for arteries below the knee

Apr 29, 2024 9:54am
visual of money going into a piggy bank

Reva returns with $45M to bring its dissolving stent to the US

Aug 10, 2022 11:46am
Nasdaq

Lyra Therapeutics wants a $58M IPO

Mar 9, 2020 8:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings